FRANCISCO BARRERA ECHEGOYEN: Open Payments
NPI 1033643242 · TACOMA, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,271 in 57 payments from 22 companies in 2025. Trend: 2023 $1,692 · 2024 $2,121 · 2025 $1,271
Food & beverage: $1,271
| Company | Payments | Amount |
|---|---|---|
| Intra-Sana Laboratories | 8 | $156 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $129 |
| Insulet Corporation | 5 | $118 |
| CeQur Corporation | 1 | $98 |
| BETA BIONICS, INC. | 4 | $97 |
| Abbott Laboratories | 4 | $78 |
| Dexcom, Inc. | 3 | $73 |
| Tandem Diabetes Care, Inc. | 3 | $60 |
| Xeris Pharmaceuticals, Inc. | 3 | $56 |
| RECORDATI_RARE_DISEASES_INC. | 2 | $52 |
Products named: RELTONE 200 MG, JARDIANCE, Omnipod, CeQur Simplicity, iLet Bionic Pancreas, FREESTYLE LIBRE 3, Dexcom G6 Transmitter, t:slim X2 Insulin Pump with Control-IQ.
Industry payments across WA — which companies pay providers there.
